Persevere Adds Biotech CEO as Cancer Drug Enters Phase 2
CHESTERBROOK, PA — Persevere Therapeutics appointed oncology executive James Barlow to its board as the Chesterbrook-based biotechnology company prepares to begin a Phase 2a trial of its experimental cancer drug …
Persevere Adds Biotech CEO as Cancer Drug Enters Phase 2 Read More